Can a smarter heart map make risky ablation safer and more effective?
NCT ID NCT06931821
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This trial compares two ways to guide ablation for ventricular tachycardia, a dangerous fast heart rhythm. One method uses standard voltage mapping to burn away all low-voltage scar tissue. The other uses a newer technique called ILAM that targets specific zones where the electrical signal slows down. The goal is to see if the ILAM-guided approach is at least as good as the standard method, with fewer complications and less heart damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Isochronal Late Activation Mapping (ILAM) guided ablation using a standard irrigated tip catheter
- What this could lead to
- If successful, this approach could make heart ablation more precise, reducing the need for repeat procedures and lowering complication rates.
- What could go wrong
- This is a non-inferiority trial, so the new method may prove no better than the current standard. The technique is also highly specialized, which may limit generalizability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT VENTRICULAR TACHYCARDIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Banner University Medical Center Phoenix
RECRUITINGPhoenix, Arizona, 85006, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.